About: Detecting the Coronavirus (COVID-19)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Detecting the Coronavirus (COVID-19) Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Detecting the Coronavirus (COVID-19)
Creator	Hu, Changpeng Mao, Hanbin Pokhrel, Pravin
Source	Medline; PMC
abstract	[Image: see text] The COVID-19 pandemic has created huge damage to society and brought panic around the world. Such panic can be ascribed to the seemingly deceptive features of COVID-19: Compared to other deadly viral outbreaks, it has medium transmission and mortality rates. As a result, the severity of the causative coronavirus, SARS-CoV-2, was deeply underestimated by society at the beginning of the COVID-19 outbreak. Based on this, in this review, we define the viruses with features similar to those of SARS-CoV-2 as the Panic Zone viruses. To contain those viruses, accurate and fast diagnosis followed by effective isolation and treatment of patients are pivotal at the early stage of virus breakouts. This is especially true when there is no cure or vaccine available for a transmissible disease, which is the case for the current COVID-19 pandemic. As of July 2020, more than 100 kits for COVID-19 diagnosis on the market have been surveyed in this review, while emerging sensing techniques for SARS-CoV-2 are also discussed. It is of critical importance to rationally use these kits for efficient management and control of the Panic Zone viruses. Therefore, we discuss guidelines to select diagnostic kits at different outbreak stages of the Panic Zone viruses, SARS-CoV-2 in particular. While it is of utmost importance to use nucleic acid based detection kits with low false negativity (high sensitivity) at the early stage of an outbreak, the low false positivity (high specificity) gains importance at later stages of the outbreak. When society is set to reopen from the lockdown stage of the COVID-19 pandemic, it becomes critical to have immunoassay based kits with high specificity to identify people who can safely return to society after their recovery from SARS-CoV-2 infections. Finally, since a massive attack from a viral pandemic requires a massive defense from the whole society, we urge both government and the private sector to research and develop affordable and reliable point-of-care testing (POCT) kits, which can be used massively by the general public (and therefore called massive POCT) to contain Panic Zone viruses in the future.
has issue date	2020-07-05(xsd:dateTime)
bibo:doi	10.1021/acssensors.0c01153
bibo:pmid	32627534
has license	no-cc
sha1sum (hex)	6517a1975c1b489df8dcf33f24426a6e298c8fb6
schema:url	https://doi.org/10.1021/acssensors.0c01153
resource representing a document's title	Detecting the Coronavirus (COVID-19)
has PubMed Central identifier	PMC7366507
has PubMed identifier	32627534
schema:publication	ACS Sens
resource representing a document's body	covid:6517a1975c1b489df8dcf33f24426a6e298c8fb6#body_text
is schema:about of	named entity 'outbreaks' named entity 'government' named entity 'based' named entity 'kits' named entity 'urge' named entity 'immunoassay' named entity 'SARS-CoV-2' named entity 'deceptive' named entity 'kits' named entity 'mortality rates' named entity 'Panic Zone' named entity 'high' named entity 'accurate' named entity 'diagnosis' named entity 'COVID-19' named entity 'pandemic' named entity 'COVID-19' named entity 'massive attack' named entity 'panic' named entity 'causative' named entity 'negativity' named entity 'viruses' named entity 'created' named entity 'COVID-19' named entity 'features' named entity 'virus' named entity 'kits' named entity 'pandemic' named entity 'acid' named entity 'COVID-19' named entity 'treatment of patients' named entity 'SARS-CoV-2' named entity 'Panic Zone' named entity 'vaccine' named entity 'COVID-19 pandemic' named entity 'mortality rates' named entity 'COVID-19' named entity 'viruses' named entity 'COVID-19 outbreak' named entity 'transmissible disease' named entity 'COVID-19 pandemic' named entity 'patients' named entity 'SARS-CoV-2' named entity 'RNA genome' named entity 'COVID' named entity 'North America' named entity 'immunoassay' named entity 'gene' named entity 'CDC' named entity 'SARS' named entity 'COVID' named entity 'genome' named entity 'COVID-19' named entity 'false negative' named entity 'COVID' named entity 'lateral flow assays' named entity 'genome' named entity 'virus' named entity 'inverse function' named entity 'concentration polarization' named entity 'data processing' named entity 'detection limit' named entity '5.7%' named entity 'PPE' named entity 'RNA' named entity 'nucleocapsid' named entity 'immune responses' named entity 'Wuhan' named entity 'false-positive' named entity 'POCT' named entity 'SARS-CoV-2' named entity 'SARS-CoV-2' named entity 'PLA' named entity 'COVID' named entity 'RNA' named entity 'Centers for Disease Control' named entity 'CT imaging' named entity 'turbidimetry' named entity 'false positive'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software